Norges Bank Axsome Therapeutics, Inc. Transaction History

Norges Bank

$634 Trillion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$57.42 - $83.61 $11.2 Million - $16.3 Million	195,123 New	195,123 $15.5 Million
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $17.8 Million - $21.1 Million	-256,397 Closed	0 $0
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $13.6 Million - $21.1 Million	-233,046 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$58.39 - $75.0 $12.3 Million - $15.8 Million	210,222 New	210,222 $13 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $10.2 Million - $20.4 Million	256,397 New	256,397 $19.8 Million

Q3 2022 Nov 13, 2023	BUY	$36.06 - $69.85 $9.25 Million - $17.9 Million	256,397 New	256,397 $11.4 Million
Q2 2022 Aug 14, 2023	BUY	$21.74 - $46.75 $5.07 Million - $10.9 Million	233,046 New	233,046 $8.93 Million
Q1 2022 May 12, 2023	SELL	$23.7 - $41.39 $1.88 Million - $3.27 Million	-79,117 Reduced 30.86%	177,280 $7.34 Million
Q1 2022 May 09, 2022	SELL	$23.7 - $41.39 $4.56 Million - $7.96 Million	-192,329 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$30.7 - $43.36 $5.9 Million - $8.34 Million	192,329 New	192,329 $7.27 Million
Q3 2021 Nov 14, 2022	BUY	$19.91 - $68.26 $3.83 Million - $13.1 Million	192,329 New	192,329 $6.34 Million
Q3 2021 Nov 05, 2021	SELL	$19.91 - $68.26 $1.24 Million - $4.25 Million	-62,223 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$50.63 - $73.5 $3.15 Million - $4.57 Million	62,223 New	62,223 $4.2 Million
Q2 2021 Aug 10, 2021	SELL	$50.63 - $73.5 $10.5 Million - $15.3 Million	-207,922 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$55.91 - $81.44 $11.6 Million - $16.9 Million	207,922 New	207,922 $11.8 Million
Q1 2021 May 07, 2021	SELL	$55.91 - $81.44 $15.4 Million - $22.4 Million	-274,909 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$66.31 - $86.52 $18.2 Million - $23.8 Million	274,909 New	274,909 $22.4 Million
Q4 2020 Feb 10, 2021	SELL	$66.31 - $86.52 $18.8 Million - $24.6 Million	-283,855 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$68.34 - $85.84 $19.4 Million - $24.4 Million	283,855 New	283,855 $20.2 Million
Q3 2020 Nov 10, 2020	SELL	$68.34 - $85.84 $27.8 Million - $34.9 Million	-406,198 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$49.87 - $98.69 $20.3 Million - $40.1 Million	406,198 New	406,198 $33.4 Million
Q2 2020 Aug 07, 2020	SELL	$49.87 - $98.69 $15.4 Million - $30.4 Million	-308,392 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$41.2 - $101.31 $12.7 Million - $31.2 Million	308,392 New	308,392 $18.1 Million

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

Rtw Investments, LP New York, NY

4.49M
Shares

$355 Million
5.75% of portfolio
Vanguard Group Inc Valley Forge, PA

3.74M
Shares

$295 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.2M
Shares

$252 Million
0.01% of portfolio
Fairmount Funds Management LLC Philadelphia, PA

2.36M
Shares

$186 Million
30.01% of portfolio
Deep Track Capital, LP Greenwich, CT

1.3M
Shares

$103 Million
3.44% of portfolio

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.38B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account